Expression of Rab5a in hepatocellular carcinoma: Possible involvement in epidermal growth factor signaling

Hepatology Research

Volumn 37, Issue 11, 2007, Pages 957-965

  Fukui, Koji ^a   Tamura, Shinji ^a   Wada, Akira ^a   Kamada, Yoshihiro ^a   Igura, Takumi ^a   Kiso, Shinichi ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidermal growth factor; Hepatocellular carcinoma; Rab5a

Indexed keywords

EPIDERMAL GROWTH FACTOR; RAB PROTEIN; RAB5A PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 34548649469     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00143.x     Document Type: Article

References (28)

1. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127 (5 Suppl. 1): S159-66.
2. Ikeda K, Saitoh S, Tsubota A et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
3. Novick P, Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 1997; 9: 496-504.
4. Vitale G, Alexandrov K, Ullrich O et al. The GDP/GTP cycle of Rab5 in the regulation of endocytotic membrane traffic. Cold Spring Harb Symp Quant Biol 1995; 60: 211-20.
5. Li Y, Meng X, Feng H, Zhang G, Liu C, Li P. Over-expression of the RAB5 gene in human lung adenocarcinoma cells with high metastatic potential. Chin Med Sci J 1999; 14: 96-101.
6. Li Y, Feng H, Chen Y. RAB5A, a gene possibly related to metastasis of human carcinoma of the lung and stomach. Zhonghua Zhong Liu Za Zhi 1999; 21: 178-81.
7. Stoscheck CM, King LE. Role of epidermal growth factor in carcinogenesis. Cancer Res 1986; 46: 1030-7.
8. Fukusato T, Mori S, Kawamoto T, Taniguchi S, Machinami R. Immunohistochemical and ultrastructural localization of epidermal growth factor receptor in human liver and hepatocellular carcinoma tissues. Acta Pathol Jpn 1990; 40: 22-9.
9. Motoo Y, Samabu N, Nakamura Y. Expression of epidermal growth factor and fibrobrast growth factor in hepatocellular carcinoma: An immunohistochemical study. Liver 1991; 11: 272-7.
10. Yamaguchi K, Brian IC, Michael AN. Concomitant and isolated expression of TGF-alpha and EGFR in human hepatoma cells supports the hypothesis of autocrine, paracrine, and endocrine growth of human hepatoma. J Surg Oncol 1995; 58: 240-5.
11. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987; 56: 881-914.
12. Barbieri MA, Roberts RL, Gumusboga A et al. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a. J Cell Biol 2000; 151: 539-50.
13. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993; 121: 163-70.
14. Bruscalupi G, Allen CM, Barbaro B, Trentalance A. Enhanced prenyltransferase activity and Rab content in rat liver regeneration. Biochem Biophys Res Commun 2000; 269: 226-31.
15. Carlin CR, Simon D, Mattison J, Knowles BB. Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines. Mol Cell Biol 1988; 8: 25-34.
16. Bucci C, Wandinger-Ness A, Luetcke A, Chiariello M, Bruni CB, Zerial M. Rab5a is a common component of the apical and basolateral endocytic machinery in polarized epithelial cells. Proc Natl Acad Sci USA 1994; 91: 5061-5.
17. Zhu A, Shaeffer J, Leslie S, Kolm P, El-Mahdi AM. Epidermal growth factor receptor: An independent predictor of survival in astrocytic tumors given definitive irradiation. Int J Radiat Oncol Biol Phys 1996; 34: 809-15.
18. Woodburn JR. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 1999; 82: 241-50.
19. Grotendorst GR, Soma Y, Takehara K, Charette M. EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol 1989; 139: 617-23.
20. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001; 37 (Suppl. 4): S9-15. Review.
21. Iihara K, Shiozaki H, Tahara H et al. Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation. Cancer 1993; 71: 2902-9.
22. Nishikawa R, Ji XD, Harmon RC et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 1994; 91: 7727-31.
23. Nagane M, Coufal F, Lin H, Bogler O, Cavenee WK, Huang HJ. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancr Res 1996; 56: 5079-86.
24. Harada K, Shiota G, Kawasaki H. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma. Liver 1999; 19: 318-25.
25. Cohen RB. Epidermal growth factor receptor as a therapeutic target in colorectal cancer. Clin Colorectal Cancer 2003; 2: 246-51.
26. Liu Y, Poon RT, Shao W et al. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. Cancer Lett 2007; 248: 32-40.
27. Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-39.
28. Lackner MR, Kindt RM, Carroll PM et al. Chemical genetics identifies Rab geranylgeranyl transferase as an apoptotic target of farnesyl transferase inhibitors. Cancer Cell 2005; 7: 325-36.